THE AROMATASE EXCESS SYNDROME IS ASSOCIATED WITH FEMINIZATION OF BOTHSEXES AND AUTOSOMAL-DOMINANT TRANSMISSION OF ABERRANT P450 AROMATASE GENE-TRANSCRIPTION
Ca. Stratakis et al., THE AROMATASE EXCESS SYNDROME IS ASSOCIATED WITH FEMINIZATION OF BOTHSEXES AND AUTOSOMAL-DOMINANT TRANSMISSION OF ABERRANT P450 AROMATASE GENE-TRANSCRIPTION, The Journal of clinical endocrinology and metabolism, 83(4), 1998, pp. 1348-1357
Increased extraglandular aromatization has been reported as the cause
of familial gynecomastia. We studied a kindred with aromatase excess i
nherited in an autosomal dominant manner, in which affected males had
heterosexual precocity and/or gynecomastia, and affected females had i
sosexual precocity and/or macromastia. The propositus was a 9-yr-old b
oy with gynecomastia. His 7.5-yr-old sister had precocious puberty, an
d their father and paternal grandmother had peripubertal gynecomastia
and macromastia, respectively. Serum concentrations of gonadal and adr
enal steroid hormones were determined before and after the administrat
ion of corticotropin and/or hCG. Aromatase activity was determined by
[H-3]Delta(4)-androstenedione to [H-3]estrone conversion by cultured,
skin fibroblasts and/or Epstein-Barr virus-transformed lymphocytes and
was detected by immunohistochemistry and/or Western analysis. Linkage
was examined with a polymorphism of the aromatase (P450arom) gene. Th
e P450arom messenger ribonucleic acid was analyzed by rapid amplificat
ion of complementary DNA (cDNA) ends, ribonuclease protection assay, a
nd RT-PCR. hCG testing demonstrated a high rate of conversion of Delta
(4)-androstenedione to estrone and of testosterone to estradiol in the
propositus and his father. Treatment of the propositus and his sister
was initiated with an aromatase inhibitor (testolactone) and a GnRH a
nalog, which successfully delayed skeletal and pubertal development In
both children. Markedly increased aromatase activity was found in the
patients' fibroblasts and Epstein-Barr virus-transformed lymphocytes.
The P450arom polymorphism segregated with the disease in the family.
A new 5'-splice variant was present in the patients' P450arom messenge
r ribonucleic acid, thus identifying yet another first exon of this ge
ne, which appears to be aberrantly expressed in this family. In conclu
sion, a family with the aromatase excess syndrome is described, in whi
ch the condition was inherited in an autosomal dominant manner, led to
feminizing manifestations in both sexes, and was associated with the
aberrant utilization of a novel transcript of the P450arom gene.